Sandoz Settles States' Generics Price-Fixing Cases For $450M
Sandoz reached a settlement with a coalition of state enforcers on Monday, agreeing to pay $450 million to end claims against it in several cases targeting alleged price-fixing in the generic-drug...To view the full article, register now.
Already a subscriber? Click here to view full article